1. The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion;Lamanna;J Oncol Pharm Practice,2017
2. Prolonged in-use stability of reconstituted herceptin in commercial intravenous bags;Nalenz;Int J Pharm Compound,2018
3. Physico-chemical stability of MabThera drug-product solution for subcutaneous injection under in-use conditions with different administration materials;Mueller;Int J Pharm Compound,2015
4. Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag;Vieillard;Ann Pharm Fr,2017
5. Low-intensity therapy in adults with Burkitt's lymphoma;Dunleavy;N Eng J Med,2013